Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free cyclosporine/Myfortic versus calcineurin inhibitor-free everolimus/Myfortic after de novo kidney transplantation
2005-004607-11Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Jan 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine, everolimus and mycophenolate sodium in kidney transplant (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Graft function at 1 year. Started Jan 2006; status: completed.
02
Drugs
cyclosporineeverolimusmycophenolate sodium
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2005-004607-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004607-11.